FDA Label for Welahead By Welmate Lidocaine 5% Roll-on
View Indications, Usage & Precautions
Welahead By Welmate Lidocaine 5% Roll-on Product Label
The following document was submitted to the FDA by the labeler of this product Otc Pharm Llc. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Active Ingredient
Lidocaine HCl 5%
Purporse
Topical Analgesic
Use
Temporarily Relieves minor pain
Warnings
For external use only
Do not use
- on large areas of the body or on cut, irritated or swollen skin
- on puncture wounds
- for more than week without consulting a doctor
- use cnly as directed. Read and follow all directions and warnings on this carton
- do not allow contact with the eyes and mucous membranes
- do not bandage or apply a local heat (such as heating pads) to the area of use
- condition worsens
- skin reactions occur, such as rash, itching, redness, irritation, pain, and swelling
- symptoms persist for more than 7 days or clear up and occur again within a days
- keep away from fire or flame
When using this product:
Stop use and aska doctor if
Flammable
If pregnant or breast freding, ask a health professional before use.
Otc - Keep Out Of Reach Of Children
Keep out of reach of children and pets. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
Adults and children over 12 years:
apply a thin layer to affeced area every 6 to 8 hours, not to exceed 3 applications in a 24 hour period
Children 12 years and younger: ask a doctor
Inactive Ingrediants
purified water, ethyl alcohol, propylene glycol, polysorbate 20, triethanolamine, phenoxyethanol, ethylhexylglycerin,
potassium carbomer, aloe vera, glycerin, chonĂ¼oitin sulfate, glucosamine sulfate, methylsulfonylmethane
* Please review the disclaimer below.